Discover how the Prostate Cancer Biorepository Network (PCBN) is accelerating prostate cancer research through standardized biological specimen collection and distribution.
Explore how advanced imaging technologies like fluciclovine PET-CT are revolutionizing detection of recurrent prostate cancer compared to conventional methods.
Groundbreaking phase II trial shows engineered tumor cells can combat prostate cancer by transforming them into antigen-presenting cells.